Case Study: Atopic Dermatitis US Phase II

Failure of sites to complete enrollment on time is a major cause of delays in clinical development programs. Relying on its expertise in dermatology, a leading pharmaceutical company engaged Novella Clinical’s patient recruitment team to assist with curtailing an enrollment timeline that was rapidly extending on a Phase II atopic dermatitis study involving 360 patients at 30 sites in across the US. This highly successful recruitment program delivered accelerated enrollment, and reduced the patient recruitment timeline by 25 weeks.